<DOC>
	<DOCNO>NCT00132704</DOCNO>
	<brief_summary>Doctors take tissue tissue remove surgery order study blood vessel tumor respond radiation therapy . The tissue obtain use determine tumor blood vessel respond radiation therapy deliver tumor , remove . This radiation deliver research lab . This research conduct order develop new method treat tumor radiation therapy . No additional surgery perform obtain sample , material remain diagnostic testing complete use .</brief_summary>
	<brief_title>An Analysis Response Human Tumor Microvascular Endothelium Ionizing Radiation</brief_title>
	<detailed_description>The goal study determine concept establish mouse model tumor microvascular response ionize radiation ( IR ) therapy applicable human tumor order begin establish engagement endothelial response valid target IR human tumor . A portion tumor isolate individual sign informed consent protocol undergo surgery Neurosurgery , Colorectal , Gynecology , Head Neck , Urology , Hepatobiliary Services Memorial Sloan-Kettering Cancer Center . Tumor tissue obtain surgical sample pathology adequate specimen obtain diagnostic purpose . Tumor tissue irradiate ex vivo microvascular endothelial response determine . From specimens adequate size , pure tumor endothelial cell population isolate response IR determine . Primary Outcomes : - To determine human tumor microvascular endothelium display similar dose parameter mouse tumor endothelium . Secondary Outcomes : - To determine tumor endothelium isolate near homogeneity demonstrate dose parameter similar use single dose radiotherapy brain tumor . - To determine microvascular endothelium tumor different type behaves similar fashion response IR .</detailed_description>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Melanoma</mesh_term>
	<mesh_term>Small Cell Lung Carcinoma</mesh_term>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Ovarian Neoplasms</mesh_term>
	<mesh_term>Liposarcoma</mesh_term>
	<criteria>Patients felt adequate tumor volume study , least 2 x 2 x 2 cm3 tumor physical exam , image study colonoscopy report Primary recurrent tumor eligible Patients must suitable candidate surgery Patients sign informed consent Patients consider suitable candidate surgery Patients receive prior radiation therapy tumor remove Patients receive chemotherapy within 6 month tumor removal Patients pregnant Patients may choose excluded time Minors exclude study expect minor tumor type investigator evaluate study</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>Lung cancer metastasis CNS ( adenocarcinoma )</keyword>
	<keyword>Melanoma metastases CNS</keyword>
	<keyword>Breast cancer metastasis CNS ( ductal carcinoma )</keyword>
	<keyword>Central nervous system glioma</keyword>
	<keyword>Colorectal cancer ( adenocarcinoma )</keyword>
	<keyword>Ovarian cancer ( papillary serous carcinoma )</keyword>
	<keyword>Endometrial cancer ( endometrioid carcinoma )</keyword>
	<keyword>Cervical cancer ( squamous cell carcinoma )</keyword>
	<keyword>Sarcomas ( liposarcomas leiomyosarcoma )</keyword>
	<keyword>Thoracic mesothelioma</keyword>
	<keyword>Colorectal cancer metastatic liver</keyword>
	<keyword>Primary adenocarcinoma lung</keyword>
	<keyword>Primary squamous cell carcinoma lung</keyword>
	<keyword>Pancreatic Cancers-adenocarcinoma</keyword>
</DOC>